(Q58125223)

1

0 references

Chryssoula Nikolaou

2

0 references

Antonis Rombos

3

0 references

Fotini Boufidou

4

0 references

Margarita Zoga

5

0 references

Antonis Dimitrakopoulos

6

0 references

Anthousa Tsoutsou

7

0 references

Demetrios Vassilopoulos

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

8

0 references

publication date

January 2007

0 references

published in

0 references

volume

8

0 references

issue

5

0 references

page(s)

283-287

0 references

cites work

Amyotrophic lateral sclerosis is a multifactorial disease

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Experimental immune-mediated motor neuron diseases: models for human ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Serum and CSF immunological findings in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Lymphocyte traffic control by chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

RANTES: a genetic risk marker for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960701419232